Free Trade Deals Are Demolishing Savings
IP Restrictions Block Generic And Biosimilar Savings Worldwide
Global free trade agreements are having a detrimental effect on savings that can be achieved by using generics and biosimilars across healthcare systems worldwide, according to a new IQVIA report hosted by the IGBA.
